✦ LIBER ✦

Acute exacerbation of Parkinson's disease with sulindac

✍ Scribed by R. Sandyk; M. A. Gillman

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 235 KB
Volume: 17
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410170124

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aripiprazole associated with severe exac

Aripiprazole associated with severe exacerbation of Parkinson's disease

✍ Mirdhu Wickremaratchi; Huw R. Morris; Imad M. Ali 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

A case of Parkinson's disease exacerbate

A case of Parkinson's disease exacerbated by fluoxetine

✍ Guy Chouinard; Sarah Sultan 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB

## Abstract Fluoxetine (Prozac®) is a potent serotonin (5‐HT) reuptake inhibitor which has rapidly gained popularity as a first‐line antidepressant due to its favourable side‐effect profile. However, it has recently been reported to worsen drug‐induced parkinsonism when used in conjunction with neu

Exacerbated physical fatigue and mental

Exacerbated physical fatigue and mental fatigue in Parkinson's disease

✍ Jau-Shin Lou; Greg Kearns; Barry Oken; Gary Sexton; John Nutt 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

## Abstract ## OBJECTIVE: To characterize fatigue in Parkinson's disease (PD). ## BACKGROUND: Fatigue is a recognized problem in PD. Fatigue can be in the physical realm or in the mental realm. Fatigue has not been characterized in PD. ## METHODS: We characterized fatigue in 39 PD patients and

Thalidomide induced acute worsening of P

Thalidomide induced acute worsening of Parkinson's disease

✍ Sara C. Crystal; John Leonidas; Ann Jakubowski; Alessandro Di Rocco 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

Acute pharmacologic blockade of dyskines

Acute pharmacologic blockade of dyskinesias in Parkinson's disease

✍ Pierre J. Blanchet; Leo Verhagen Metman; M. Maral Mouradian; Thomas N. Chase 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

Homocysteine levels after acute levodopa

Homocysteine levels after acute levodopa intake in patients with Parkinson's disease

✍ Thomas Müller; Wilfried Kuhn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

## Abstract Levodopa (L‐dopa) administered with a dopadecarboxylase inhibitor (DDI) increases homocysteine plasma levels. This may support the onset of atherosclerosis‐related disorders and neuropsychiatric complications in patients with Parkinson's disease (PD). This homocysteine elevation is cons